Detecting cancer margins during breast surgery
Part of Cancer, Skin clinical trials.
This study tests a new method to check for leftover cancer cells and lymph node spread during breast surgery. It may help doctors make sure all cancer is removed the first time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a wide local excision (breast surgery that removes the tumor with a small rim of healthy tissue).
- You are able to understand and sign a consent form.
- There is no uncertainty about your breast cancer diagnosis from your prior biopsy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new laser scanner that helps doctors see if all cancer cells are removed during breast-conserving surgery, which might reduce the need for a second operation.
This study tests whether a special microscope can help surgeons see cancer margins (edges) during prostate removal surgery to make sure all cancer is removed. It may help surgeons make real-time decisions about how much tissue to remove.
This trial is testing a new way to identify cancer tissue during breast surgery. It may help surgeons remove cancer more completely during a lumpectomy.
This study tests a scanner (Histolog®) that checks the edges of removed breast tissue during surgery to make sure all cancer is removed. The goal is to reduce the need for a second surgery.
This trial tests a microscope-like scanner that helps surgeons see if all cancer cells have been removed during breast-conserving surgery. It may reduce the need for a second surgery by checking the removed tissue immediately.
This trial tests a new method using tiny particles that glow when they find cancer cells on the edges of removed breast tissue and in lymph nodes. The goal is to help surgeons see if any cancer is left behind during the same surgery, so they can remove it right away.
Hear when a new Breast Cancer Invasive trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.